To determine whether CD8+ T cell-mediated antitumor immunity was involved in the R848@M2pep-MPsAFP-induced anticancer activity, anti-CD8 antibody was used to deplete CD8+ T cells in the orthotopic Hepa1-6 tumor-bearing mice (Supplementary Fig. 26a). The gene discussed is CD8A; the disease is neoplasm.